AZTA
Azenta, Inc.NASDAQHealthcare$22.63+6.85%ClosedMarket Cap: $1.04B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.61
P/S
1.75
EV/EBITDA
15.06
DCF Value
$12.81
FCF Yield
3.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.3%
Operating Margin
-1.3%
Net Margin
-9.7%
ROE
-3.4%
ROA
-4.5%
ROIC
4.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $148.6M | 42.9% | $-4.9M | $-15.4M | $-0.34 | — |
| Q4 2025 | $159.2M | 45.4% | $2.9M | $50.9M | $1.02 | — |
| FY 2025 | $593.8M | 45.5% | $-11.3M | $-55.8M | $-1.22 | — |
| Q3 2025 | $143.9M | 47.1% | $1.6M | $-52.8M | $-1.15 | — |
| Q2 2025 | $143.4M | 45.9% | $-7.4M | $-40.5M | $-0.88 | — |
| Q1 2025 | $147.4M | 46.7% | $-3.7M | $-11.0M | $-0.29 | — |
| Q4 2024 | $150.6M | 45.5% | $6.1M | $-6.6M | $-0.10 | — |
| FY 2024 | $573.4M | 44.4% | $-30.0M | $-164.9M | $-3.09 | — |
| Q3 2024 | $144.3M | 45.4% | $-4.2M | $-6.6M | $-0.12 | — |
| Q2 2024 | $136.4M | 44.5% | $-12.0M | $-136.9M | $-2.47 | — |
| Q1 2024 | $141.7M | 39.8% | $-15.4M | $-15.7M | $-0.28 | — |
| Q4 2023 | $172.4M | 35.1% | $-14.5M | $3.4M | $0.06 | — |